BioGuard UVC™ – Medical UV Mask for Hospital Infection Prevention
Kills Viruses at the Source | Protects Everyone in the Room
BioGuard UVC™ is a personal, wearable pathogen inactivation device that prevents the spread of respiratory disease by inactivating airborne pathogens in exhaled breath. Unlike traditional masks that filter or trap particles, BioGuard UVC actively kills viruses, bacteria, and other pathogens in the exhaled breath of infected individuals before they can spread.
About BioGuard UVC – A New Category of Solution to Respiratory Infections
We help prevent the spread of respiratory disease in healthcare settings by neutralizing pathogens in the exhaled breath of infected individuals. BioGuard UVC is 100x more effective than any alternative solution. Our patented UVC disinfection technology achieves what no others can – we stop the rain before it starts by killing viruses at the source.
Respiratory Infection is the #1 cause of Hospital Acquired Infections in Emergency Departments. With mandatory CDC reporting starting January 1, 2025, hospitals face penalties for high HAI rates. BioGuard UVC provides the solution for hospital infection prevention and respiratory infection control.
Why Now?
- January 1, 2025: CDC established mandatory HAI reporting
- Payors penalize hospitals with high HAIs (±1%)
- U.S. Patent granted July 1st, 2025 – Patent 12,343,572
- U.S. Congressional support with funding directive
Award-Winning Medical UV Device
🏆 Winner of 2025 Leader in Life Sciences in NJ
🏆 Winner of 2025 Coolest Thing Made in NJ
🏆 2026 EY Entrepreneur Of The Year® NJ Regional Finalist
Market Opportunity and Pathogen Inactivation Statistics
15 Million – Annual Emergency Department visits for respiratory infections in the U.S.
$3 Billion – U.S. market opportunity for Emergency Departments alone
99.9999% – Pathogen inactivation rate achieved by BioGuard UVC medical UV mask
© 2026 Geared Power BioTech, Inc. | U.S. Patent 12,343,572 | EP4126257 | EP4364817